# MYRIAD GENETICS INC (MYGN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MYGN/

- Reporting holders: 3
- Reported value: $77.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Williams & Novak Wealth Management, LLC](https://holderbook.com/funds/1998419-williams-novak-wealth-management-llc/) | $66.8K | 15,500 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $6.0K | 1,396 | 0.0% | 16 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.2K | 984 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $77.1K |
| Q2 2026 | 198 | $562.4M |
| Q1 2026 | 202 | $524.4M |
| Q4 2025 | 222 | $570.5M |
| Q3 2025 | 222 | $653.1M |
| Q2 2025 | 219 | $483.2M |
| Q1 2025 | 226 | $837.4M |
| Q4 2024 | 221 | $1.3B |
| Q3 2024 | 245 | $2.5B |
| Q2 2024 | 223 | $2.3B |
| Q1 2024 | 187 | $2.1B |
| Q4 2023 | 194 | $1.7B |